Kimmel H L, Gong W, Vechia S D, Hunter R G, Kuhar M J
Yerkes Regional Primate Research Center, Emory University, Atlanta, Georgia 30329, USA.
J Pharmacol Exp Ther. 2000 Aug;294(2):784-92.
Cocaine- and amphetamine-regulated transcript (CART) is a novel mRNA that has been reported to be increased by acute psychostimulant administration, and that may be involved in the effects of psychostimulants. In this study, we examined the effect of centrally administered CART peptides on locomotor activity and conditioned place preference in the rat. CART peptide fragments were bilaterally injected into the ventral tegmental area. CART 55-102 (0.2-5.0 microg/side), an endogenously occurring peptide, dose dependently increased locomotor activity, whereas CART 1-26 (0.1-2.5 microg/side; not found endogenously) did not. The locomotor effects of CART 55-102 were dose dependently blocked by the dopamine D(2) receptor antagonist haloperidol (0.03-1.0 mg/kg i.p.). Four injections of 1.0 microg/side CART 55-102 induced a significant place preference, suggesting that CART 55-102 is reinforcing. Increases in locomotor activity after each of these CART 55-102 injections were similar and did not show tolerance or sensitization. This treatment regimen of CART 55-102 also did not produce sensitization to locomotor activity after a subsequent challenge with cocaine or amphetamine. When CART 55-102 (0.2-1.0 microg/side) was injected into the substantia nigra, no significant change in motor activity was observed. However, a higher dose of CART 55-102 (5.0 microg/side) induced a delayed increase in motor activity, suggesting a possible diffusion from the substantia nigra into the ventral tegmental area. Our findings suggest that CART 55-102 is behaviorally active and may be involved in the actions of psychostimulants. This is the first demonstration of the psychostimulant-like effects of CART peptides.
可卡因和苯丙胺调节转录物(CART)是一种新型信使核糖核酸,据报道,急性给予精神兴奋剂可使其增加,且其可能与精神兴奋剂的作用有关。在本研究中,我们检测了向大鼠脑内注射CART肽对其运动活性和条件性位置偏爱行为的影响。将CART肽片段双侧注射到腹侧被盖区。内源性存在的肽CART 55 - 102(0.2 - 5.0微克/侧)剂量依赖性地增加运动活性,而CART 1 - 26(0.1 - 2.5微克/侧;内源性未发现)则无此作用。CART 55 - 102的运动效应被多巴胺D(2)受体拮抗剂氟哌啶醇(0.03 - 1.0毫克/千克,腹腔注射)剂量依赖性地阻断。每侧注射1.0微克CART 55 - 102共4次可诱导出显著的位置偏爱,表明CART 55 - 102具有强化作用。每次注射这些剂量的CART 55 - 102后运动活性的增加相似,且未表现出耐受或敏感化。在随后用可卡因或苯丙胺激发后,这种CART 55 - 102的治疗方案也未产生对运动活性的敏感化。当将CART 55 - 102(0.2 - 1.0微克/侧)注射到黑质时,未观察到运动活性有显著变化。然而,较高剂量的CART(5.0微克/侧)可诱导运动活性延迟增加,提示可能从黑质扩散到腹侧被盖区。我们的研究结果表明,CART 55 - 102具有行为活性,可能参与精神兴奋剂的作用。这是首次证明CART肽具有类似精神兴奋剂的作用。